In 2008, a consortium of concerned international NGOs and advocacy organisations introduced the NGO Code of Conduct for Health System Strengthening, which highlighted how disproportionate funding for NGOs, rather than for public sector health systems, has undermined public services in many developing countries.The NGO Code of Conduct outlines a set of proposed best practices for NGOs to support local public services. However, after promoting the NGO Code of Conduct for 5 years, the behaviour of some NGOs seems unlikely to change unless donors hold them accountable for adhering to these best practices.
27 August 2014 | The Lancet
The .com’s and .net’s of the world have a new, more charitable neighbor to welcome online. A new initiative called dotHIV officially launched Tuesday with plans to sell .HIV domain names to web creators as part of a fundraising effort to fight and prevent HIV and AIDS. Companies and individuals can purchase .HIV domain names for $179, and a small donation will be made to an HIV- or AIDS-related charity each time a web user visits the site.
26 August 2014 | Re/code
The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.
21 August 2014 | Global Fund to Fight AIDS, TB and Malaria
The inspector general of the U.S. Department of Health and Human Services finds Medicare spent tens of millions of dollars in 2012 for HIV drugs there’s little evidence patients needed. A 77-year-old woman with no record of HIV got $33,500 of medication.
06 August 2014 | ProPublica
In the latest salvo fired over the cost of hepatitis C treatments, a new report projects that the cost of these drugs – including the Sovaldi medication sold by Gilead Sciences – will increase 2015 federal spending by Medicare Part D between $2.9 billion to $5.8 billion.
05 August 2014 | Wall Street Journal
The Live Aid founder said there had been incredible advances in the fight against HIV and AIDS in the past 30 years, but that final steps were the most crucial.
24 July 2014 | ABC News
The USAID- and PEPFAR-funded Health Policy Project’s own estimates of the global costs of reaching extremely high levels of ART coverage in low and middle-income countries suggest that between U.S.$5.5 to $9 billion might be required annually to meet this goal by 2020.
24 July 2014 | Science Speaks
Harm Reduction International, the International Drug Policy Consortium and the International HIV/Aids Alliance will publish a report that confirms HIV prevention services for drug injectors are losing out due to "changing donor policies and national government neglect".
20 July 2014 | The Observer
Investment in HIV prevention research fell US$50 million, or 4 percent, to US$1.26 billion in 2013, due to declining investments by the United States and European government donors, changes in the international development landscape and changes in the pipeline of HIV prevention products in various stages of development and implementation, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group.
20 July 2014 | HIV Vaccines and Microbicides Resource Tracking Working Group press release
Donor governments in 2013 committed US$8.1 billion in new funding to support the AIDS response in low- and middle-income countries, down 3 percent from 2012, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) released in advance of the 2014 International AIDS Conference.
19 July 2014 | Kaiser Family Foundation